Daniel S. van Riper
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chip McClure | M | 70 | 7 years | |
| Thomas W. Erickson | M | 73 | 9 years | |
| William Edward Curran | M | 75 | 16 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Johnson | M | 49 | 18 years | |
| Abraham Nethanel Reichental | M | 67 | 12 years | |
| Arnold Lippa | M | 77 |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | 11 years |
| Damon Joseph Gregoire | M | 56 | 8 years | |
| T. J. Dermot Dunphy | M | 92 | 31 years | |
| William J. Marino | M | 73 | 16 years | |
| Vyomesh Joshi | M | 70 | 4 years | |
| Peter Diamandis | M | 62 | 3 years | |
| David Robert Styka | M | 62 | 1 years | |
| Kenneth P. Manning | M | 82 | - | |
| William David Humes | M | 59 | 8 years | |
| Theodore A. Hull | M | 67 | 1 years | |
| Jeffrey Wadsworth | M | 74 | 5 years | |
| Karen E. Welke | F | 79 | 9 years | |
| Robert M. Grace | M | 76 | 9 years | |
| Cathy L. Lewis | F | 72 | 7 years | |
| Thomas E. Bocchino | M | 65 |
New Brunswick Scientific Co., Inc.
 New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | 6 years |
| Michael Chu | M | 75 | 18 years | |
| Samuel Eichenbaum | M | - |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | - |
| Carol O'Neill | F | - | 5 years | |
| Ilan Erez | M | 56 | 4 years | |
| John N. McMullen | M | 65 | 3 years | |
| Ping Fu | F | 65 | 3 years | |
| Ran Bronstein | M | 60 | - | |
| William Joseph Murphy | M | 80 |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | - |
| Scott Myers | M | 57 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | 2 years |
| Stuart Apfel | M | 63 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | 2 years |
| Philip C. Schultz | M | - | 4 years | |
| Dennis Podlesak | M | 66 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | - |
| Andrew Christensen | M | 50 | - | |
| William James Adams | M | - | - | |
| Jon Fong | M | - | 7 years | |
| Liz von Hasseln | F | - | 5 years | |
| Jeff Blank | M | - | 7 years | |
| Peter Theran | M | - | - | |
| Mark William Wright | M | 60 | 2 years | |
| Charlie Grace | M | 58 | 2 years | |
| Neal Orringer | M | - | 5 years | |
| Menno Ellis | M | - | 8 years | |
| Joseph Zakrzewski | M | 60 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | 1 years |
| David Kelsey | M | 73 | 9 years | |
| Jerome Birnbaum | M | 84 |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | 7 years |
| Leslie Hudson | M | 76 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | 1 years |
| David Freedman | M | 74 |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | 48 years |
| Ernest Gross | M | 105 |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | 23 years |
| Kenneth M. Freedman | M | 65 |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | 8 years |
| Peter A. Schkeeper | M | 79 |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | 8 years |
| Mark T. Becker | M | 65 | 2 years | |
| J. Stuart K. Prosser | M | 78 | 7 years | |
| James Donald Tate | M | 72 | - | |
| Joel Jaffe | M | - |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | - |
| Frederick Smagorinsky | M | 63 | - | |
| Assad A. Ansari | M | 77 | - | |
| Cary J. Love | M | 59 | - | |
| Theresa A. Bischoff | F | 69 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | - |
| Brian Kenneth Fraser | M | 62 | - | |
| William Joseph Tennison | M | 73 | 1 years | |
| Fred R. Jones | M | 76 | 4 years | |
| Gerald J. Pribanic | M | 80 | - | |
| Hugh Evans | M | 58 | 6 years | |
| J. Robert Horton | M | 88 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | - |
| David Pramer | M | 101 |
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | 45 years |
| Manuel Mondragón | M | 74 | - | |
| Jonathan Silverstein | M | 57 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | - |
| Hugh L. Sargant | M | 75 | - | |
| Warren C. Stern | M | 79 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | - |
| Allen Latty | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 70 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Daniel S. van Riper
- Personal Network
